Rxsight Correlations

RXST Stock  USD 8.69  0.22  2.47%   
The current 90-days correlation between Rxsight and Neuropace is -0.03 (i.e., Good diversification). The correlation of Rxsight is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Rxsight Correlation With Market

Significant diversification

The correlation between Rxsight and DJI is 0.08 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Rxsight and DJI in the same portfolio, assuming nothing else is changed.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rxsight. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For more information on how to buy Rxsight Stock please use our How to Invest in Rxsight guide.

Moving against Rxsight Stock

  0.57CMWCF Cromwell PropertyPairCorr
  0.5ASG Aurora Spine CorpPairCorr
  0.66ELUT Elutia IncPairCorr
  0.58NKTX Nkarta IncPairCorr
  0.52MMC MMC Old Symbol ChangePairCorr
  0.5ODC Oil DriPairCorr
  0.37ATMV ATMV Old Symbol ChangePairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

TCMDNPCE
CERSBFLY
KIDSNPCE
CERSTCMD
DMACNPCE
DCTHBFLY
  

High negative correlations

TMCITCMD
TMCINPCE
CERSTMCI
DMACTMCI
TMCIBFLY
TMCIKIDS

Risk-Adjusted Indicators

There is a big difference between Rxsight Stock performing well and Rxsight Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Rxsight's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
NPCE  3.02  0.58  0.25  0.29  2.17 
 6.30 
 43.20 
TCMD  2.67  1.08  0.61  1.81  1.07 
 7.40 
 46.16 
SMLR  49.98  23.87  4.11  0.89  4.86 
 18.45 
 1,670 
KIDS  1.88 (0.02) 0.00  0.04  2.16 
 3.72 
 16.89 
BFLY  5.41  1.06  0.22  0.44  4.61 
 14.22 
 42.22 
TMCI  3.38 (1.38) 0.00  2.60  0.00 
 5.60 
 31.38 
DMAC  3.32  0.30  0.08  0.19  4.15 
 7.69 
 24.12 
CERS  3.67  0.65  0.17  0.39  3.49 
 10.19 
 30.94 
DCTH  1.99 (0.09) 0.00 (0.02) 0.00 
 4.57 
 13.50 
SRDX  1.90  0.48  0.24  3.68  1.26 
 2.09 
 49.69 

Rxsight Corporate Management

Jim SchindlerSenior CounselProfile
Adam DasheExecutive InternationalProfile
Matt HallerChief OfficerProfile
Alex HuangInvestor RelationsProfile
Oliver MoravcevicVice RelationsProfile
Patrick CullenExecutive OperationsProfile